Phase I Clinical Study of Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke
The study is to determine the safety of human neural stem cell transplantation for the treatment of paralysis and related symptoms due to chronic motor stroke and to determine the maximum tolerated dose.
100 Clinical Results associated with Suzhou Neuralstem Biopharmaceutical Co., Ltd
0 Patents (Medical) associated with Suzhou Neuralstem Biopharmaceutical Co., Ltd
100 Deals associated with Suzhou Neuralstem Biopharmaceutical Co., Ltd
100 Translational Medicine associated with Suzhou Neuralstem Biopharmaceutical Co., Ltd